Characterization of ERK Docking Domain Inhibitors that Induce Apoptosis by Targeting Rsk-1 and Caspase-9
2011

Inhibitors of ERK Docking Domain Induce Cancer Cell Death

publication Evidence: moderate

Author Information

Author(s): Boston Sarice R, Deshmukh Rahul, Strome Scott, Priyakumar U Deva, MacKerell Alexander D Jr, Shapiro Paul

Primary Institution: University of Maryland

Hypothesis

Can low-molecular weight compounds selectively inhibit ERK1/2 docking sites to induce apoptosis in cancer cells without affecting normal cells?

Conclusion

The study identifies a class of ERK-targeted molecules that induce apoptosis in cancer cells by inhibiting ERK-mediated phosphorylation of pro-apoptotic proteins.

Supporting Evidence

  • Compounds 76.2, 76.3, and 76.4 inhibited proliferation and induced apoptosis in HeLa cells.
  • The active compounds were less effective in inhibiting proliferation or inducing apoptosis in non-transformed epithelial cells.
  • Induction of HeLa cell apoptosis involved caspase-9 activation and decreased phosphorylation of the pro-apoptotic Bad protein.
  • Compounds 76.3 and 76.4 directly inhibited ERK-mediated phosphorylation of caspase-9 and p90Rsk-1.

Takeaway

Some special compounds can help cancer cells die by blocking signals that keep them alive, while not hurting normal cells.

Methodology

The study used computational modeling, cell proliferation assays, immunoblotting, and caspase activity assays to evaluate the effects of test compounds on cancer cells.

Limitations

The compounds were less effective in non-transformed epithelial cells, indicating potential selectivity issues.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-11-7

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication